SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
Mark Anderson, Michael Stec, Ayesan Rewane, Alan Landay, Gavin Cloherty, James N. Moy
Abstract
This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.
Topics & Concepts
Antibody responseMedicineAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CohortVirologyImmunologyCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing